Wallace Advisory Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$70.1K Hold
11,711
0.07% 123
2025
Q4
$84K Sell
11,711
-316
-3% -$2.5K 0.09% 128
2025
Q3
$116K Buy
12,027
+316
+3% +$3.1K 0.09% 165
2025
Q2
$174K Hold
11,711
0.13% 167
2025
Q1
$175K Hold
11,711
0.12% 181
2024
Q4
$224K Hold
11,711
0.15% 164
2024
Q3
$242K Hold
11,711
0.18% 153
2024
Q2
$242K Hold
11,711
0.17% 154
2024
Q1
$169K Hold
11,711
0.13% 165
2023
Q4
$203K Hold
11,711
0.16% 153
2023
Q3
$244K Hold
11,711
0.18% 142
2023
Q2
$275K Hold
11,711
0.21% 125
2023
Q1
$275K Hold
11,711
0.21% 125
2022
Q4
$327K Buy
+11,711
New +$299K 0.26% 107

Other funds holding OGN

Wallace Advisory Group's OGN Position: Q1 2026 in Review

Wallace Advisory Group held its Organon & Co (OGN) position steady in Q1 2026 at 11,711 shares worth $70.1K. The position accounts for 0.07% of the portfolio, ranked #123.

Wallace Advisory Group first reported a position in OGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $327K in Q4 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Wallace Advisory Group held 11,711 shares of Organon & Co worth $70.1K as of Q1 2026.
  • Wallace Advisory Group left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up 0.07% of Wallace Advisory Group's portfolio in Q1 2026, its #123 holding.
  • Wallace Advisory Group first reported a position in Organon & Co in Q4 2022 and has held it in 14 quarters since.
  • Wallace Advisory Group's Organon & Co position peaked at $327K in Q4 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Wallace Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.